F. Calabrese

569 total citations
19 papers, 361 citations indexed

About

F. Calabrese is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, F. Calabrese has authored 19 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 3 papers in Surgery. Recurrent topics in F. Calabrese's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Myasthenia Gravis and Thymoma (3 papers) and Cancer Treatment and Pharmacology (3 papers). F. Calabrese is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Myasthenia Gravis and Thymoma (3 papers) and Cancer Treatment and Pharmacology (3 papers). F. Calabrese collaborates with scholars based in Italy, Spain and United States. F. Calabrese's co-authors include Marianna Gnoato, Carlo Agostini, Antonella Teramo, Elisa Ave, Sara Teolato, Cristina Gattazzo, Anna Cabrelle, Gianpietro Semenzato, Gian Paolo Fadini and Giuseppe Marulli and has published in prestigious journals such as Journal of Clinical Oncology, Thorax and European Journal of Cardio-Thoracic Surgery.

In The Last Decade

F. Calabrese

18 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Calabrese Italy	7	213	167	78	70	41	19	361
Athina Trachalaki Greece	12	298 1.4×	95 0.6×	26 0.3×	52 0.7×	117 2.9×	23	444
Eleni Bibaki Greece	10	261 1.2×	82 0.5×	22 0.3×	47 0.7×	102 2.5×	16	370
Eli P. Darnell United States	6	167 0.8×	96 0.6×	258 3.3×	34 0.5×	60 1.5×	10	406
Takeshi Kamimura Japan	8	100 0.5×	51 0.3×	27 0.3×	34 0.5×	107 2.6×	21	331
Timo Effenberger Germany	5	123 0.6×	171 1.0×	74 0.9×	12 0.2×	66 1.6×	6	348
Fumiaki Hino Japan	9	68 0.3×	38 0.2×	156 2.0×	143 2.0×	32 0.8×	18	361
Sip Dinkla Netherlands	9	116 0.5×	202 1.2×	49 0.6×	33 0.5×	163 4.0×	12	460
Alexandros Papalambros Greece	12	99 0.5×	21 0.1×	161 2.1×	45 0.6×	90 2.2×	25	402
Toshiro Miwa Japan	11	123 0.6×	67 0.4×	163 2.1×	57 0.8×	64 1.6×	43	362
Adriano Carneiro da Costa Italy	11	70 0.3×	33 0.2×	164 2.1×	33 0.5×	77 1.9×	48	376

Countries citing papers authored by F. Calabrese

Since Specialization

Citations

This map shows the geographic impact of F. Calabrese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Calabrese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Calabrese more than expected).

Fields of papers citing papers by F. Calabrese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Calabrese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Calabrese. The network helps show where F. Calabrese may publish in the future.

Co-authorship network of co-authors of F. Calabrese

This figure shows the co-authorship network connecting the top 25 collaborators of F. Calabrese. A scholar is included among the top collaborators of F. Calabrese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Calabrese. F. Calabrese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Faccioli, Eleonora, Federica Pezzuto, Andrea Dell’Amore, et al.. (2021). Fatal Early-Onset Invasive Aspergillosis in a Recipient Receiving Lungs from a Marijuana-Smoking Donor. The Journal of Heart and Lung Transplantation. 40(4). S512–S512.

Pasello, Giulia, Jessica Menis, Sara Pilotto, et al.. (2020). How covid-19 pandemic impacted integrated care pathways for lung cancer: the experience of two Italian centers in veneto region. Tumori. 106. 73–74. 1 indexed citations

Cardone, Claudia, Erika Martinelli, Teresa Troiani, et al.. (2019). Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer. ESMO Open. 4(4). e000519–e000519. 4 indexed citations

Petrillo, Angelica, F. Calabrese, Giuseppe Tirino, et al.. (2019). First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: a good choice beyond age. Journal of Gastrointestinal Oncology. 10(5). 910–917. 15 indexed citations

Petrillo, Angelica, Luca Pompella, Giuseppe Tirino, et al.. (2019). Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment. Medical Oncology. 36(10). 83–83. 3 indexed citations

Buonerba, Carlo, Margaret Ottaviano, Piera Federico, et al.. (2014). Capecitabine plus gemcitabine in thymic epithelial tumors: Final analysis of a phase II trial.. Journal of Clinical Oncology. 32(15_suppl). 7528–7528. 6 indexed citations

Palmieri, Giovannella, Piera Federico, Margaret Ottaviano, et al.. (2014). A case series of low-dose sorafenib plus tamoxifen in sorafenib-pretreated patients with advanced hepatocellular carcinoma.. Journal of Clinical Oncology. 32(15_suppl). e15139–e15139. 1 indexed citations

Palmieri, Giovannella, Carlo Buonerba, Margaret Ottaviano, et al.. (2014). Capecitabine Plus Gemcitabine in Thymic Epithelial Tumors: Final Analysis of a Phase II Trial. Future Oncology. 10(14). 2141–2147. 27 indexed citations

Zuin, Andrea, Giuseppe Marulli, Marco Schiavon, et al.. (2013). Is lobectomy really more effective than sublobar resection in the surgical treatment of second primary lung cancer?. European Journal of Cardio-Thoracic Surgery. 44(2). e120–e125. 53 indexed citations

10.

Moretto, Roberto, Chiara Alessandra Cella, Lucia Raimondo, et al.. (2013). Tumor-to-tumor metastasis. Anti-Cancer Drugs. 24(7). 759–764. 4 indexed citations

11.

Molena, Béatrice, Paolo Sfriso, Francesca Oliviero, et al.. (2011). Synovial colony-stimulating factor-1 mRNA expression in diffuse pigmented villonodular synovitis.. PubMed. 29(3). 547–50. 14 indexed citations

12.

Loy, M., Francesco Chiara, Elisabetta Balestro, et al.. (2010). 338: End Stage Idiopathic Pulmonary Fibrosis: Which Patients Are at Higher Risk of Mortality Awaiting Lung Transplantation?. The Journal of Heart and Lung Transplantation. 29(2). S114–S114. 1 indexed citations

13.

Cabrelle, Anna, Antonella Teramo, Marianna Gnoato, et al.. (2010). Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax. 66(2). 144–150. 194 indexed citations

14.

Fiocco, Ugo, Paolo Sfriso, Francesca Oliviero, et al.. (2009). Synovial fluid and synovial tissue biomarkers of the response to intra-articular TNF-α blockade in psoriatic arthritis. Research Padua Archive (University of Padua). 1 indexed citations

15.

Calabrese, F., Francesca Lunardi, Cinzia Giacometti, et al.. (2008). Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations. Thorax. 63(9). 795–802. 29 indexed citations

16.

Calabrese, F., et al.. (2006). A Methodology for Searching Reusable Business Processes. 153–153. 3 indexed citations

17.

Calabrese, F., et al.. (2006). Business Processes Characterisation Through Definition of Structural and Non-Structural Criteria. 132–132. 2 indexed citations

18.

Negri, L, et al.. (1992). [Chemotherapy and thymostimulin in the treatment of advanced-stage breast neoplasms].. PubMed. 83(5). 283–8. 2 indexed citations

19.

Fazio, Maurizio, et al.. (1992). The LMI test in colon, breast and lung cancer long survivors.. PubMed. 34(2). 60–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact